0 results available. Select is focused ,type to refine list, press Down to open the menu,
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company’s ...
The following section summarizes insights on Tarsus Pharmaceuticals Inc's 1 Month Price Total Return:
We've identified the following companies as similar to Tarsus Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to 1 Month Price Total Return in the valuation category include:
The total change in price (adjusted of dividends and splits when applicable) over the last 1 month.
The 1 month price total return measures the total change in price (adjusted of dividends and splits when applicable) over the last 1 month. If the company pays dividends, the starting stock price is adjusted down to include the return in the form of dividends.
Last Close Price / Adj Prior Close Price
(-) 1
(=) Total Return
One Month Stock Price Total Return for Tarsus Pharmaceuticals is calculated as follows:
Last Close Price [ 51.91 ] / Adj Prior Close Price [ 48.92 ]
(-) 1
(=) Total Return [ 6.1% ]
Prior price dividend adjustment factor is 1.00.
Read more about price close (split adjusted) and dividend adjustment factor
The chart above depicts the distribution of 1 month price total return for companies operating in the Healthcare sector in the Developed economic region. Over 2,970 companies were considered in this analysis, and 2,859 had meaningful values. The average 1 month price total return of companies in the sector is 0.1% with a standard deviation of 18.5%.
Tarsus Pharmaceuticals Inc's 1 Month Price Total Return of 6.1% ranks in the 75.9% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,979 |
| Included Constituents | 2,859 |
| Min | -62.5% |
| Max | 92.4% |
| Median | 0.0% |
| Mean | 0.1% |
| Standard Deviation | 18.5% |
You can find companies with similar 1 month price total return using this stock screener.